| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 20306-22-3 | 1,4-环己二甲酸二烯丙酯 (顺反混合物) | diallyl 1,4-cyclohexanedicarboxylate (cis- and trans- mixture) | C14H20O4 | 252.31 | | |
| 20306-38-1 | | 2-methoxyethyl n-phenylcarbamate | | | | |
| 20306-74-5 | 1-(丙-2-炔-1-基)-1H-吡唑 | 1-(PROP-2-YN-1-YL)-1H-PYRAZOLE | C6H6N2 | 106.13 | | 172.6±23.0 °C(Predicted) |
| 20306-75-6 | 乙酰乙酰胺一甲酯 | Butanamide,N-methyl-3-oxo- | C5H9NO2 | 115.13 | -3℃ | 106℃ |
| 203061-99-8 | | 4-ethyl-1h-pyrazol-3-amine hydrochloride | | | | |
| 203065-88-7 | 2-[4-(三氟甲基)苯基]吡啶 | 2-[4-(trifluoromethyl)phenyl]pyridine | C12H8F3N | 223.2 | 74-78°C | |
| 203066-04-0 | 2-amino-3-cyclohexylpropanamide | | C9H18N2O | 170.256 | | |
| 203067-00-9 | | 3'-fluoro-4'-n-propoxyacetophenone | | | | |
| 20307-83-9 | β- 倍半水芹烯 | (-)-β-Sesquiphellandrene | C16H24 | 204.35 | | 90-90.5 °C at 1 Torr (lit.) |
| 203070-78-4 | 9,9-芴二乙醇 | 9,9-bis(2-hydroxyethyl)fluorene | C17H18O2 | 254.32 | | |
| 20308-43-4 | | n-pentyl-benzamid | | | | |
| 20309-70-0 | 2-乙酰基-5-甲氧苯基β-d-吡喃葡萄糖苷 | 2-acetyl-5-methoxyphenyl β-d-glucopyranoside | | | | |
| 20309-77-7 | | trans-1,1,3,4-tetramethylcyclopentane | C9H18 | 126.24 | | |
| 20309-87-9 | | 4-methyleneproline | | | | |
| 2031-23-4 | | 1-(3-chloropropyl)-4-methylpiperazine dihydrochloride | C8H19Cl3N2 | 249.61 | | |
| 2031-62-1 | 甲基二乙氧基硅烷 | diethoxy-methyl-silane | C5H14O2Si | 134.25 | | 94℃ |
| 2031-67-6 | 三乙氧基甲基硅烷 | methyl triethoxyl silane | C7H18O3Si | 178.30 | | 141-143℃ |
| 2031-77-8 | | decaethyl-tetrasiloxane | C20H50O3Si4 | 450.95 | | |
| 2031-78-9 | | dodecaethyl-pentasiloxane | C24H60O4Si5 | 553.16 | | |
| 2031-79-0 | 乙基D3 | 1,1,3,3,5,5-Hexaethylcyclotrisiloxane | C12H30O3Si3 | 306.62 | 14℃ | 117℃(10 |
| 2031-90-5 | | pentane-d12 | C5D12 | 84.22 | | 36℃ |
| 20310-60-5 | | adenosine 5'-(trihydrogen pyrophosphate), magnesium salt | | | | |
| 20310-82-1 | | Ryanodol 4-bromobenzylether | C27H37BrO8 | 569.48 | | |
| 20310-89-8 | 肥皂草苷 | | | | | |
| 20311-41-5 | 甲氧基黄叱精 | Methoxychrysoidine | C13H14N4O | | | |
| 20311-51-7 | | solamargine | C45H73NO15 | 868.07 | 200-203 °C | |
| 20311-78-8 | | enanthotoxin | | | | |
| 2031148-34-0 | | kat7, active, gst tagged human | | | | |
| 203115-63-3 | 1,1′-(2,2-dimethyl-1,3-propanediyl)bis[3,4-dichloro-1h-pyrrole-2,5-dione | nsc 617145 | C13H10Cl4N2O4 | 400.04 | | |
| 203115-91-7 | | 1-fluoro-2-propoxybenzene | | | | |
| 203115-93-9 | | 1-fluoro-3-isopropoxybenzene | | | | |
| 203115-97-3 | | 3-fluoro-4-n-propoxybenzoic acid | | | | |
| 2031153-61-2 | Iscalimab单抗 | Iscalimab | | | | |
| 2031161-35-8 | UT-155 | | C20H15F4N3O2 | 405.35 | | |
| 2031170-80-4 | 3'-(3,5-二氯-4-羟基苯氧基)-6'-羟基螺[2-苯并呋喃-3,9'-氧杂蒽]-1-酮 | 3'-(3,5-dichloro-4-hydroxyphenoxy)-6'-hydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one | C26H14Cl2O6 | 493.29 | | |
| 2031177-48-5 | ZM223 | | C23H17F3N4O2S2 | 502.53 | | |
| 2031185-00-7 | N-(4-甲基-3-((4-(5-(4-甲基异恶唑-5-基)吡啶-3-基)嘧啶-2-基)氨基)苯基)-4-((4-甲基哌嗪-1-基)甲基)苯甲酰胺 | N-(4-Methyl-3-((4-(5-(4-methylisoxazol-5-yl)pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide | C33H34N8O2 | 574.68 | | |
| 20312-36-1 | | l(-)-3-phenyllactic acid | C9H10O3 | 166.17 | 121-125℃ | |
| 20312-37-2 | | (R)-2-hydroxy-4-methylpentanoic acid | C6H12O3 | 132.16 | | 251.3°C at 760 mmHg |
| 20312-38-3 | | cis-1-(p-Chlorophenyl)-3-isopropyl-4-phenyl-2-azetidinone | C18H18ClNO | 299.80 | | |
| 203120-17-6 | | (2R,3R,4S)-3-acetamido-2-((1R,2R)-2,3-dihydroxy-1-methoxypropyl)-4-guanidino-3,4-dihydro-2h-pyran-6-carboxylic acid | | | | |
| 203124-56-5 | | 2'-carboxy-2,2,2,-trifluoroacetophenone | | | | |
| 2031242-60-9 | (R)-1-乙基哌啶-3-胺二盐酸盐 | (R)-1-Ethylpiperidin-3-aminedihydrochloride | C7H18Cl2N2 | 201.14 | | |
| 2031248-31-2 | 2-Ethoxycarbonylcyclopropane boronic acid | | C6H11BO4 | 157.96014 | | |
| 2031255-23-7 | 1-((R)-3-(4-((3-((R)-3-(4-氨基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-d]嘧啶-1-基)哌啶-1-基)-3氧丙基)氨基)-3-(4-苯氧苯基)-1H-吡唑并[3,4-d]嘧啶-1-基)哌啶-1-基)丙-2-烯-1-酮(伊布替尼/依鲁替尼杂质) | 1-((R)-3-(4-((3-((R)-3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3-oxopropyl)amino)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one(IbrutinibImpurity) | C50H48N12O4 | 880.99 | | |
| 2031255-25-9 | (S)-1-((R)-1-丙烯酰基哌啶-3-基)-4-氨基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-d]嘧啶1-氧化物(依鲁替尼杂质) | (S)-1-((R)-1-Acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine1-oxide(IbrutinibImpurity) | C25H24N6O3 | 456.5 | | |
| 2031255-26-0 | 依鲁替尼杂质15(伊布替尼/依鲁替尼杂质) | IbrutinibImpurity15(IbrutinibImpurity) | C26H28N6O3 | 472.54 | | |
| 2031258-51-0 | 2-氮杂螺环[3.4]辛烷-1-羧酸甲酯 | Methyl 2-azaspiro[3.4]octane-1-carboxylate | C9H15NO2 | 169.22 | | |
| 2031259-33-1 | 1-(2,6-二氟苯基)环丁胺盐酸盐 | 1-(2,6-difluorophenyl)cyclobutanamine hydrochloride | | | | |
| 2031259-79-5 | 2-tert-butyl 4-methyl 2-azabicyclo[2.2.2]octane-2,4-dicarboxylate | | C14H23NO4 | 269.341 | | |
m.cnreagent.com